Concurrent Low Intensity Shockwave Therapy on Collagenase Clostridium Histolyticum for Peyronie's Disease

Abroad (travel likely)Recruiting

Conditions

Peyronie Disease · Erectile Dysfunction

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Mayo Clinic Minnesota, Rochester, Minnesota, United States
Contact: Study coordinator (Wyatt H Anians, CCRP) · Anians.Wyatt@mayo.edu · 507-538-6151

Study leads

Tobias Kohler, MD
Principal Investigator
Mayo Clinic

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Delayed Dose Collagenase Clostridium Histolyticum (CCH) Protocol for Men With Peyronie's Disease

Peyronie Disease

Abroad (travel likely)RecruitingPHASE4

Orem, United States

Extracorporeal Shockwave Therapy in the Treatment of Peyronie's Disease

Peyronie Disease

Abroad (travel likely)Recruiting

Baku, Azerbaijan

Platelet-Rich Plasma Injections From Cord Blood + Penile Traction vs. Penile Traction Alone in Patients With Peyronie's Disease. Open-label, Single-center Randomized Study

Peyronie Disease · Penile Curvature · PRP Injection

Abroad (travel likely)Recruiting

Milan, Italy

Safety of Cultured Allogeneic Adult Umbilical Cord Stem Cells for Peyronie's Disease, ED, and Interstitial Cystitis

Erectile Dysfunction · Peyronie's Disease · Interstitial Cystitis

Abroad (travel likely)RecruitingPHASE1

St John's, Antigua and Barbuda